Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)
Hong Kong · Delayed Price · Currency is HKD 2.650
+0.260 (10.88%)
Sep 11, 2026, 4:08 PM HKT
HKG:2427 Revenue
Guanze Medical Information Industry (Holding) had revenue of 28.43M CNY in the half year ending June 30, 2026, a decrease of -28.97%. This brings the company's revenue in the last twelve months to 85.02M, down -42.38% year-over-year. In the year 2025, Guanze Medical Information Industry (Holding) had annual revenue of 88.45M, down -43.21%.
Revenue (ttm)
85.02M CNY
Revenue Growth
-42.38%
P/S Ratio
23.13
Revenue / Employee
1.52M CNY
Employees
56
Market Cap
2.27B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 88.45M | -67.29M | -43.21% |
| Dec 31, 2024 | 155.74M | -332.00K | -0.21% |
| Dec 31, 2023 | 156.07M | -21.04M | -11.88% |
| Dec 31, 2022 | 177.11M | -33.96M | -16.09% |
| Dec 31, 2021 | 211.08M | 26.64M | 14.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 8.02B |
| Adicon Holdings | 3.06B |
| Kindstar Globalgene Technology | 1.10B |
| Yunkang Group | 624.49M |
| Mega Genomics | 413.73M |
| Biosino Bio-Technology and Science Incorporation | 196.98M |
| Zhong Ji Longevity Science Group | 150.07M |
| King International Investment | 143.23M |